Several inflammatory markers have prognostic impact in renal cell carcinoma (RCC), including acute phase proteins, e.g., C-reactive protein and ferritin, but also derivatives of complete blood count such as monocytes, platelets, or lymphocytes levels [1,2]. The gene discussed is CRP; the disease is renal cell carcinoma.